These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9375283)

  • 1. Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma.
    Rosen A; Casciola-Rosen L; Wigley F
    Curr Opin Rheumatol; 1997 Nov; 9(6):538-43. PubMed ID: 9375283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis.
    Casciola-Rosen L; Wigley F; Rosen A
    J Exp Med; 1997 Jan; 185(1):71-9. PubMed ID: 8996243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in scleroderma.
    Pollard KM; Reimer G; Tan EM
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in scleroderma.
    Rothfield NF
    Rheum Dis Clin North Am; 1992 May; 18(2):483-98. PubMed ID: 1626078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited.
    Gabrielli A; Svegliati S; Moroncini G; Pomponio G; Santillo M; Avvedimento EV
    Semin Immunopathol; 2008 Jul; 30(3):329-37. PubMed ID: 18548250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
    Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
    Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity and oxidatively modified autoantigens.
    Kurien BT; Scofield RH
    Autoimmun Rev; 2008 Jul; 7(7):567-73. PubMed ID: 18625446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes.
    Reimer G; Scheer U; Peters JM; Tan EM
    J Immunol; 1986 Dec; 137(12):3802-8. PubMed ID: 3537125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidatively modified autoantigens in autoimmune diseases.
    Kurien BT; Hensley K; Bachmann M; Scofield RH
    Free Radic Biol Med; 2006 Aug; 41(4):549-56. PubMed ID: 16863987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in scleroderma and tightskin mice.
    Bona C; Rothfield N
    Curr Opin Immunol; 1994 Dec; 6(6):931-7. PubMed ID: 7710717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes.
    Muryoi T; Kasturi KN; Kafina MJ; Cram DS; Harrison LC; Sasaki T; Bona CA
    J Exp Med; 1992 Apr; 175(4):1103-9. PubMed ID: 1372644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of scleroderma. Current concepts.
    Lee EB; Anhalt GJ; Voorhees JJ; Diaz LA
    Int J Dermatol; 1984 Mar; 23(2):85-9. PubMed ID: 6698691
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoantibody to RNA polymerase I in scleroderma sera.
    Reimer G; Rose KM; Scheer U; Tan EM
    J Clin Invest; 1987 Jan; 79(1):65-72. PubMed ID: 2432091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U3 snoRNP associates with fibrillarin a component of the scleroderma clumpy nucleolar domain.
    Herrera-Esparza R; Kruse L; von Essen M; Campos L; Barbosa O; Bollain JJ; Badillo I; Avalos-Díaz E
    Arch Dermatol Res; 2002 Oct; 294(7):310-7. PubMed ID: 12373336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunofluorescence study with an autoantinucleolus antiserum from a scleroderma patient as compared with silver staining].
    Young Y
    Shi Yan Sheng Wu Xue Bao; 1986 Mar; 19(1):39-51. PubMed ID: 2426879
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex.
    Alderuccio F; Chan EK; Tan EM
    J Exp Med; 1991 Apr; 173(4):941-52. PubMed ID: 2007859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts.
    Zhou X; Tan FK; Xiong M; Milewicz DM; Feghali CA; Fritzler MJ; Reveille JD; Arnett FC
    J Immunol; 2001 Dec; 167(12):7126-33. PubMed ID: 11739535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular autoantigens: diagnostic fingerprints but aetiological dilemmas.
    Tan EM; Reimer G; Sullivan K
    Ciba Found Symp; 1987; 129():25-42. PubMed ID: 3315505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radical proposal for the pathogenesis of scleroderma.
    Murrell DF
    J Am Acad Dermatol; 1993 Jan; 28(1):78-85. PubMed ID: 8425975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.